Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $22,142 - $25,231
-95 Reduced 12.68%
654 $162,000
Q2 2023

Aug 09, 2023

BUY
$224.99 - $256.14 $27,898 - $31,761
124 Added 19.84%
749 $179,000
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $51,786 - $59,832
216 Added 52.81%
625 $157,000
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $11,588 - $13,549
48 Added 13.3%
409 $108,000
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $10,870 - $66,325
-44 Reduced 10.86%
361 $93,000
Q2 2022

Aug 08, 2022

SELL
$237.11 - $299.66 $79,194 - $100,086
-334 Reduced 45.2%
405 $103,000
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $24,955 - $30,628
-97 Reduced 11.6%
739 $217,000
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $23,658 - $26,649
-81 Reduced 8.83%
836 $275,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $151,076 - $184,498
-555 Reduced 37.7%
917 $279,000
Q2 2021

Aug 10, 2021

BUY
$225.08 - $271.69 $42,315 - $51,077
188 Added 14.64%
1,472 $395,000
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $413,928 - $479,259
-1,949 Reduced 60.28%
1,284 $289,000
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $131,325 - $151,694
618 Added 23.63%
3,233 $718,000
Q3 2020

Oct 30, 2020

SELL
$177.16 - $215.33 $98,500 - $119,723
-556 Reduced 17.53%
2,615 $563,000
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $1.93 Million - $2.65 Million
-15,006 Reduced 82.55%
3,171 $561,000
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $2.21 Million - $3.07 Million
18,177 New
18,177 $926,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.